SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TRUMP is a politics-themed digital coin built on the Solana blockchain that uses the brand of Donald Trump to foster a community-driven ecosystem. As a community-focused asset, it is designed to bridge political support with web ownership, operating within the PolitiFi sector to blend political movements with decentralized finance tools. The project's main value proposition lies in its official ties to Donald Trump’s media and business brands, which allows it to provide unique physical utility such as invitations to gala dinners and meetings at Mar-a-Lago.  The token serves as the primary currency for the officially licensed Trump Billionaires Club mobile and web game, where it is used for in-game purchases and unlocking features. By leveraging the Solana blockchain, the project ensures that these in-game actions and token transfers remain fast and cost-effective. The ecosystem remains stable through a programmatic release schedule that introduces new tokens slowly to prevent supply shocks, alongside the use of specialized market makers to maintain consistent liquidity for traders.  Holders can also participate in liquidity sharing by providing their tokens to automated systems to facilitate trading for others, often earning rewards or prizes in return. Beyond digital utility, holding a specific amount of the token is a requirement for attending exclusive real-world events, including VIP parties at Mar-a-Lago. The project is managed by the Trump Meme Team and is linked with Trump Media, with an investor base that includes a wide range of retail buyers and large holders who utilize secure custody services for their assets.

Trump For President

$TRUMP.X is trending as the community debates its volatility, with bulls highlighting the token as a high-risk meme play while critics consistently label it as a pump-and-dump scheme. Discussions center on the coin's drastic price decline since its peak and ongoing scrutiny surrounding the Trump family's financial ties to various crypto projects.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is surging following a sector-wide rally in mRNA stocks sparked by positive cancer vaccine data from major industry players. Investors are increasingly optimistic about the company's proprietary LUNAR delivery platform and its rare disease pipeline, viewing it as an undervalued asset that is becoming difficult to dismiss despite its smaller market capitalization compared to major peers.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is surging as investors cheer a significant earnings beat and raised guidance, highlighting the company's role as a critical partner in the AI infrastructure and memory-efficient computing space. While some community members are focused on the stock's rapid gains and potential for further upside, others are debating the sustainability of the rally, noting valuation concerns and the implications of its recent convertible note offering.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending following a positive FDA meeting that confirmed the regulatory path for its wet AMD drug, AXPAXLI, with an NDA filing now targeted for late 2026. The community is actively discussing the potential for a buyout, while also debating the competitive impact of the company's trial designs compared to peers like EyePoint Pharmaceuticals.

Pump.fun

Pump.fun is trending as investors debate its recent performance amidst platform revenue growth, community-led buyback efforts, and ongoing legal challenges. Despite these headwinds, the community remains divided between those capitalizing on the high trading volume and those concerned about the sustainability of the meme-heavy ecosystem.

HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in July 2007 and is headquartered in Mountain View, CA.

Heartflow Inc

Heartflow, Inc.

HeartFlow is experiencing high volatility as traders debate whether the stock is undergoing a manipulative pump or a genuine breakout, with many pointing to heavy insider selling and stretched valuations despite recent strong earnings. Community members are actively split between calling for a short position due to the stock's parabolic climb and holding for potential long-term AI-driven growth.

Freddie Mac engages in the provision of housing finance system solutions. It operates through the Single-Family and Multifamily segments. The Single-Family segment is involved in purchase, securitization, and guarantee of single-family loans, investments, and management of single-family mortgage credit risk and market risk. The Multifamily segment focuses on purchase, securitization, and guarantee of multifamily loans, investments, securities, and management of multifamily mortgage credit risk and market risk. The company was founded on July 24, 1970 and is headquartered in McLean, VA.

Federal Home Loan Mortgage Corp

Freddie Mac

Investors are closely tracking potential policy shifts following comments from Freddie Mac leadership regarding the readiness for a public offering, leading to active community debate over the timing of a release from conservatorship. Conversations are heavily focused on the interplay between mortgage market conditions, upcoming regulatory reports, and the administration's stated goals for housing finance reform.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Investors are actively debating the potential for Fannie Mae to be released from conservatorship, fueled by rumors of a massive IPO under the current administration. Discussions frequently highlight the influence of high-profile investors like Bill Ackman and Michael Burry, alongside leadership changes at the FHFA, as key signals for a potential long-term breakout.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is surging amid unconfirmed buyout rumors, with traders speculating on potential interest from major biopharma companies as its MS drug Briumvi continues to gain strong market momentum. Community discussions are heavily focused on the stock's long-term valuation, potential acquisition premiums, and confidence in leadership's strategic growth plans.

Workday, Inc. engages in the development of enterprise cloud applications for finance and human resources. The firm delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. It operates through the Cloud Applications segment. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday is trending as investors weigh unconfirmed reports of a potential multi-billion dollar private equity buyout against recent earnings performance and sector-wide software volatility. The community remains divided, with some traders betting on a deal premium while others express skepticism over the lack of official confirmation and the broader implications of private equity interest in enterprise software.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RoboStrategy, Inc. is generating significant buzz as investors view it as a unique vehicle for accessing high-growth private robotics and physical AI companies like Figure AI. The community is actively debating the stock's valuation, insider commitments, and its potential to replicate the volatile momentum seen in similar closed-end funds.

RoboStrategy Stock: A High-Risk, High-Reward Opportunity for Long-Term Investors

RoboStrategy (NASDAQ: BOT) gives investors exposure to robotics, automation, and physical AI companies through a public stock. The upside is compelling if private robotics leaders gain value over time, but the premium to reported net asset value makes the risk-reward setup unusua...

GiantLeap Capital Announces Strategic Investment in Standard Bots, America's Largest Manufacturer of AI-Native Industrial Robots

GiantLeap Capital Announces Strategic Investment in Standard Bots, America's Largest Manufacturer of AI-Native Industrial Robots GiantLeap Capital Announces Strategic Investment in Standard Bots, America's Largest Manufacturer of AI-Native Industrial Robots PR Newswire NEW YORK, June 11, 2026...

Standard Bots Raises $200 Million Series C at $1 Billion Valuation to Scale American-Made, AI-Native Industrial Robots

Standard Bots Raises $200 Million Series C at $1 Billion Valuation to Scale American-Made, AI-Native Industrial Robots Standard Bots Raises $200 Million Series C at $1 Billion Valuation to Scale American-Made, AI-Native Industrial Robots PR Newswire NEW YORK, June 9, 2026 Standard Bots is on pace...

RoboStrategy CEO Explains Why He Shifted Focus From Crypto To Physical AI – Calls RoboStrategy The ‘MicroStrategy Of Robotics’

Equity

Andrew Kang increased his stake from $1 million to $19 million after betting on Figure AI in late 2023, a move his usual VC network cautioned against.

RoboStrategy is a venture capital investment firm that publicly trades a fund giving investors access to private & public companies leading in robotics and embodied AI.

RoboStrategy Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

BOT RoboStrategy, Inc.

Fundamentals

Connect Stocktwits to ChatGPT

Latest BOT News